Evidence map›Paper›PMID 41499248›Full record

ArticleBrain : a journal of neurology2026

Multimodal multicentre investigation of diagnostic and prognostic markers in disorders of consciousness.

Dragana Manasova, Laouen Mayal Louan Belloli, Martin Justinus Rosenfelder, Lina Willacker, Emilia Fló Rama, Chiara Valota, Bertrand Hermann, Brigitte Charlotte Kaufmann, Alice Pirastru, Chiara Camilla Derchi and 27 more

Abstract readMulticenter Study
In one paragraph

Article in Brain : a journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Dragana ManasovaInstitut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.ORCID 0000-0002-2756-3263
Laouen Mayal Louan BelloliInstitut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.
Martin Justinus RosenfelderDepartment of Neurology, University Hospital of the Ludwig-Maximilians-Universität München, Munich 82152, Germany.
Lina WillackerDepartment of Neurology, University Hospital of the Ludwig-Maximilians-Universität München, Munich 82152, Germany.
Emilia Fló RamaInstitut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.
Chiara ValotaDepartment of Biomedical and Clinical Sciences, University of Milano, Milan 20157, Italy.
Bertrand HermannInserm 1266, Institute of Psychiatry and Neurosciences of Paris, Université Paris Cité, Paris F-75014, France.ORCID 0000-0001-9071-3415
Brigitte Charlotte KaufmannInstitut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.
Alice PirastruIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan 20148, Italy.ORCID 0000-0001-9474-2344
Chiara Camilla DerchiIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan 20148, Italy.
Theresa RaiserDepartment of Neurology, University Hospital of the Ludwig-Maximilians-Universität München, Munich 82152, Germany.
Melanie ValenteInstitut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.
Aude SangareInstitut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.
Başak TürkerInstitut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.
Nadya PyatigorskayaInstitut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.
Benoît BérangerInstitut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.
Michele ColomboDepartment of Biomedical and Clinical Sciences, University of Milano, Milan 20157, Italy.
Esteban Munoz-MusatInstitut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.
Anira EscrichsCenter for Brain and Cognition, Computational Neuroscience Group, Universitat Pompeu Fabra, Barcelona 08005, Spain.ORCID 0000-0002-6482-9737
Tiziana AtzoriIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan 20148, Italy.
Francesca BaglioIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan 20148, Italy.
Constantin LapaNuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg 86156, Germany.ORCID 0000-0001-7536-2207
Ansgar BerlisDiagnostic and Interventional Neuroradiology, Faculty of Medicine, University of Augsburg, Augsburg 86156, Germany.
Kristina KrügerDiagnostic and Interventional Neuroradiology, Faculty of Medicine, University of Augsburg, Augsburg 86156, Germany.
Tina LutherDepartment of Neurology, University Hospital of the Ludwig-Maximilians-Universität München, Munich 82152, Germany.
Vincent PerlbargBRAINTALE SAS, Paris 75013, France.
Gustavo DecoCenter for Brain and Cognition, Computational Neuroscience Group, Universitat Pompeu Fabra, Barcelona 08005, Spain.
Yonathan Sanz-PerlInstitut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.ORCID 0000-0002-1270-5564
Enzo TagliazucchiConsejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ministry of Science, Technology and Innovation, Buenos Aires C1053, Argentina.
Louis PuybassetBRAINTALE SAS, Paris 75013, France.
Benjamin RohautInstitut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.ORCID 0000-0001-6752-8756
Lionel NaccacheInstitut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.ORCID 0000-0002-2874-1009
Angela ComanducciIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan 20148, Italy.
Anat ArziInstitut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.
Mario RosanovaDepartment of Biomedical and Clinical Sciences, University of Milano, Milan 20157, Italy.
Andreas BenderDepartment of Neurology, University Hospital of the Ludwig-Maximilians-Universität München, Munich 82152, Germany.
Jacobo Diego SittInstitut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Sorbonne Université, Paris 75013, France.

Funding

Agence Nationale de la Recherche ANR-19-PERM-0002Ecole Doctorale Frontières de l'Innovation en Recherche et Education-Programme BettencourtFederal Ministry of Education and Research 01KU2003Fondazione Regionale per la Ricerca Biomedica GA 77982Italian Ministry of HealthMODELDxConsciousness Consortium JTC 2023Paris Brain Institute
6 · The paper itself

Abstract

Severely brain-injured patients may enter a spectrum of conditions collectively known as disorders of consciousness. This spectrum includes clinical conditions such as unresponsive wakefulness syndrome or minimally conscious state, where the behavioural assessment of consciousness can often be deceptive. To bridge this dissociation, neuroimaging techniques are employed to identify the residual brain functions. Each neuroimaging modality imperfectly captures distinct aspects of brain preservation-functional, anatomical, or both. In this study, we adopt a comprehensive approach by integrating the neurophysiology and neuroimaging modalities available from the standard and advanced clinical assessments through interpretable machine learning. The electrophysiological modalities included high-density EEG (resting state and task), whereas neuroimaging modalities included anatomical and resting-state functional MRI, diffusion MRI and 18F-fluorodeoxyglucose PET. Our investigation reveals that specific modalities, such as functional assessments, provide comprehensive insights into the currently evaluated state of consciousness, the diagnosis of the patients. Conversely, structural modalities offer valuable information about the patient's evolution within the consciousness spectrum. We validate the proposed analysis with data coming from other centres with different acquisition parameters. Importantly, we demonstrate that model performance improves with an increase in the number of modalities. We observe a higher inter-modality disagreement for minimally conscious state patients and those patients who improve. Lastly, we observe a difference in feature importances between diagnosis and prognosis, with an interaction between modality and anatomical structures: some subcortical markers tend to contribute more to prognosis, while other cortical markers are more informative for diagnosis. This integrative multimodal and machine learning methodology presents a promising avenue for a more nuanced understanding of disorders of consciousness, contributing to enhanced diagnostic precision, prognostic capabilities and the personalization of rehabilitative strategies in clinical practice.

Indexed as

BrainConsciousness DisordersMultimodal ImagingNeuroimagingAdultElectroencephalographyFemaleHumansMachine LearningMagnetic Resonance ImagingMaleMiddle AgedPositron-Emission TomographyPrognosisdisorders of consciousnesselectrophysiologymachine learningmultimodalneuroimaging

Identifiers

PMID41499248
PMCPMC13058464

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.